Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Artificial Nasolacrimal Duct Market by Type (Mono Canalicular Stents, Canalicular Stents), By Application (Hospitals, Clinics, Others) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Artificial Nasolacrimal Duct Market by Type (Mono Canalicular Stents, Canalicular Stents), By Application (Hospitals, Clinics, Others) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 169653 3300 Medical Devices & Consumables 377 243 Pages 4.7 (39)
                                          

Market Overview:


The global artificial nasolacrimal duct market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of dry eye syndrome, rising awareness about the benefits of using artificial nasolacrimal ducts, and technological advancements in this field. Based on type, the global artificial nasolacrimal duct market can be segmented into mono canalicular stents and canalicular stents. Mono canalicular stents are more commonly used than canalicular stents due to their simplicity and low cost. Canalicular stents are more expensive than mono canalicular stents but offer several advantages such as better drainage and reduced risk of infection. Based on application, the global artificial nasolacrimal duct market can be segmented into hospitals, clinics, and others (including research institutes). Hospitals account for a major share of the overall demand for artificial nasolacrimal ducts owing to increasing number of ophthalmic surgeries being performed in these institutions every year. Clinics are also expected to witness significant growth during the forecast period owing to rising demand for ophthalmic services across emerging economies such as India and China.


Global Artificial Nasolacrimal Duct Industry Outlook


Product Definition:


The artificial nasolacrimal duct is a surgically created passage between the nose and eye. It is used to bypass a blockage in the natural nasolacrimal duct, which drains tears from the eyes. The artificial nasolacrimal duct may be necessary if a child has frequent eye infections or other problems with drainage of tears.


Mono Canalicular Stents:


Mono canalicular stents are used to treat blocked nose, or inability to produce normal tears. These devices are inserted into the nasal passage and help in clearing blockages present there. The stent is a hollow tube made up of flexible material such as plastic which helps in pushing the foreign body upward along with opening up a path for tears to flow normally.


Canalicular Stents:


Artificial nasolacrimal duct is a device used to drain fluid from the nose and lacrimal system of patients. It works by creating an artificial pathway for fluid to flow from the nasal cavity through the canal into the Lacrimal System. The stents are small, hollow plastic tubes that are inserted into both sides of the nose. They help in maintaining patency of canals and prevent it from drying up due to blockage or infection.


Application Insights:


Based on the application, the market is segmented into hospitals, clinics and ophthalmic centers, and others. Hospitals held the largest share in 2017 owing to a large patient base with various disorders of lacrimal system that require nasolacrimal duct stenting for proper treatment. The availability of advanced healthcare facilities along with highly skilled medical professionals in several countries including China, India, Brazil has boosted product demand from Asia Pacific region.


The others segment includes patients referred by general physicians or ENT surgeons for diagnostic purposes as well as those diagnosed through self-referral or family-referral at clinics or ophthalmic centers.


Regional Analysis:


North America dominated the global market in 2017. This can be attributed to increasing awareness about various treatment options, high disposable income, and availability of advanced medical devices. Moreover, presence of key players such as Medtronic; Boston Scientific Corporation; Bausch & Lomb; and Novartis AG is also expected to boost the growth over the forecast period.


Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising number of patients suffering from dry eye disease coupled with growing healthcare expenditure in emerging countries such as China and India. In addition, increasing prevalence of glaucoma may further drive this regional market during the forecast period. For instance, according to a study published by National Eye Institute (NIH), approximately 60 million people are living with glaucoma globally out of which 30 million reside in China while 10 million reside in India’s case-fatality rate for nasolacrimal duct obstruction ranges from 2%to 3%.


Growth Factors:


  • Increasing prevalence of dry eye syndrome
  • Growing awareness about the benefits of artificial nasolacrimal ducts
  • Rising demand for minimally invasive procedures
  • Technological advancements in artificial nasolacrimal ducts surgery
  • increasing incidence of congenital anomalies

Scope Of The Report

Report Attributes

Report Details

Report Title

Artificial Nasolacrimal Duct Market Research Report

By Type

Mono Canalicular Stents, Canalicular Stents

By Application

Hospitals, Clinics, Others

By Companies

Beaver-Visitec International, Kaneka, Bess Medizintechnik GmbH, FCI Ophthalmics, Fruida, Sinopsys Surgical

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

243

Number of Tables & Figures

171

Customization Available

Yes, the report can be customized as per your need.


Global Artificial Nasolacrimal Duct Market Report Segments:

The global Artificial Nasolacrimal Duct market is segmented on the basis of:

Types

Mono Canalicular Stents, Canalicular Stents

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Hospitals, Clinics, Others

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Beaver-Visitec International
  2. Kaneka
  3. Bess Medizintechnik GmbH
  4. FCI Ophthalmics
  5. Fruida
  6. Sinopsys Surgical

Global Artificial Nasolacrimal Duct Market Overview


Highlights of The Artificial Nasolacrimal Duct Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Mono Canalicular Stents
    2. Canalicular Stents
  1. By Application:

    1. Hospitals
    2. Clinics
    3. Others
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Artificial Nasolacrimal Duct Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Artificial Nasolacrimal Duct Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


The artificial nasolacrimal duct is a surgically created opening in the upper eyelid that allows Tears and other fluids to drain from the eyes.

Some of the key players operating in the artificial nasolacrimal duct market are Beaver-Visitec International, Kaneka, Bess Medizintechnik GmbH, FCI Ophthalmics, Fruida, Sinopsys Surgical.

The artificial nasolacrimal duct market is expected to grow at a compound annual growth rate of 5.5%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Artificial Nasolacrimal Duct Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Artificial Nasolacrimal Duct Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Artificial Nasolacrimal Duct Market - Supply Chain
   4.5. Global Artificial Nasolacrimal Duct Market Forecast
      4.5.1. Artificial Nasolacrimal Duct Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Artificial Nasolacrimal Duct Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Artificial Nasolacrimal Duct Market Absolute $ Opportunity

5. Global Artificial Nasolacrimal Duct Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Artificial Nasolacrimal Duct Market Size and Volume Forecast by Type
      5.3.1. Mono Canalicular Stents
      5.3.2. Canalicular Stents
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Artificial Nasolacrimal Duct Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Artificial Nasolacrimal Duct Market Size and Volume Forecast by Application
      6.3.1. Hospitals
      6.3.2. Clinics
      6.3.3. Others
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Artificial Nasolacrimal Duct Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Artificial Nasolacrimal Duct Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Artificial Nasolacrimal Duct Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Artificial Nasolacrimal Duct Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Artificial Nasolacrimal Duct Demand Share Forecast, 2019-2026

9. North America Artificial Nasolacrimal Duct Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Artificial Nasolacrimal Duct Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Artificial Nasolacrimal Duct Market Size and Volume Forecast by Application
      9.4.1. Hospitals
      9.4.2. Clinics
      9.4.3. Others
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Artificial Nasolacrimal Duct Market Size and Volume Forecast by Type
      9.7.1. Mono Canalicular Stents
      9.7.2. Canalicular Stents
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Artificial Nasolacrimal Duct Demand Share Forecast, 2019-2026

10. Latin America Artificial Nasolacrimal Duct Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Artificial Nasolacrimal Duct Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Artificial Nasolacrimal Duct Market Size and Volume Forecast by Application
      10.4.1. Hospitals
      10.4.2. Clinics
      10.4.3. Others
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Artificial Nasolacrimal Duct Market Size and Volume Forecast by Type
      10.7.1. Mono Canalicular Stents
      10.7.2. Canalicular Stents
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Artificial Nasolacrimal Duct Demand Share Forecast, 2019-2026

11. Europe Artificial Nasolacrimal Duct Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Artificial Nasolacrimal Duct Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Artificial Nasolacrimal Duct Market Size and Volume Forecast by Application
      11.4.1. Hospitals
      11.4.2. Clinics
      11.4.3. Others
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Artificial Nasolacrimal Duct Market Size and Volume Forecast by Type
      11.7.1. Mono Canalicular Stents
      11.7.2. Canalicular Stents
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Artificial Nasolacrimal Duct Demand Share, 2019-2026

12. Asia Pacific Artificial Nasolacrimal Duct Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Artificial Nasolacrimal Duct Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Artificial Nasolacrimal Duct Market Size and Volume Forecast by Application
      12.4.1. Hospitals
      12.4.2. Clinics
      12.4.3. Others
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Artificial Nasolacrimal Duct Market Size and Volume Forecast by Type
      12.7.1. Mono Canalicular Stents
      12.7.2. Canalicular Stents
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Artificial Nasolacrimal Duct Demand Share, 2019-2026

13. Middle East & Africa Artificial Nasolacrimal Duct Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Artificial Nasolacrimal Duct Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Artificial Nasolacrimal Duct Market Size and Volume Forecast by Application
      13.4.1. Hospitals
      13.4.2. Clinics
      13.4.3. Others
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Artificial Nasolacrimal Duct Market Size and Volume Forecast by Type
      13.7.1. Mono Canalicular Stents
      13.7.2. Canalicular Stents
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Artificial Nasolacrimal Duct Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Artificial Nasolacrimal Duct Market: Market Share Analysis
   14.2. Artificial Nasolacrimal Duct Distributors and Customers
   14.3. Artificial Nasolacrimal Duct Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Beaver-Visitec International
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Kaneka
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Bess Medizintechnik GmbH
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. FCI Ophthalmics
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Fruida
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Sinopsys Surgical
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. COMPANY7
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. COMPANY8
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. COMPANY9
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. COMPANY 10
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. COMPANY 11
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. COMPANY 12
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. COMPANY 13
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us